BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10541986)

  • 1. Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution.
    Krcmery V; Mrazova M; Kunova A; Grey E; Mardiak J; Jurga L; Sabo A; Sufliarsky J; Sevcikova L; Sorkovska D; West D; Trupl J; Novotny J; Mateicka F
    Support Care Cancer; 1999 Nov; 7(6):428-31. PubMed ID: 10541986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
    Krcmery V; Oravcova E; Spanik S; Mrazova-Studena M; Trupl J; Kunova A; Stopkova-Grey K; Kukuckova E; Krupova I; Demitrovicova A; Kralovicova K
    J Antimicrob Chemother; 1998 Mar; 41(3):373-80. PubMed ID: 9578164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
    J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group.
    Krcméry V; Kovacicová G
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):7-11. PubMed ID: 10744362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
    Krcméry V; Spánik S; Grausová S; Trupl J; Krupová I; Roidová A; Sálek T; Sufliarsky J; Mardiak J
    Neoplasma; 1998; 45(5):336-42. PubMed ID: 9921924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
    Bodey GP; Mardani M; Hanna HA; Boktour M; Abbas J; Girgawy E; Hachem RY; Kontoyiannis DP; Raad II
    Am J Med; 2002 Apr; 112(5):380-5. PubMed ID: 11904112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
    Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
    J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).
    Bretagne S; Renaudat C; Desnos-Ollivier M; Sitbon K; Lortholary O; Dromer F;
    J Antimicrob Chemother; 2017 Jun; 72(6):1784-1793. PubMed ID: 28333259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
    Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I
    Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
    Colombo AL
    Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
    Hope W; Morton A; Eisen DP
    J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
    Luzzati R; Allegranzi B; Antozzi L; Masala L; Pegoraro E; Azzini A; Concia E
    Clin Microbiol Infect; 2005 Nov; 11(11):908-13. PubMed ID: 16216107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungemia in cancer patients in Brazil: predominance of non-albicans species.
    Nucci M; Silveira MI; Spector N; Silveira F; Velasco E; Martins CA; Derossi A; Colombo AL; Pulcheri W
    Mycopathologia; 1998; 141(2):65-8. PubMed ID: 9750336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.
    Krcmery V; Spanik S; Kunova A; Trupl J; Grausova S; Krupova I; Mateicka F; Pichnova E; Grey E; Sabo A
    J Chemother; 1999 Apr; 11(2):131-6. PubMed ID: 10326744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.